Compare SHASUN PHARMA with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ALEMBIC LTD SHASUN PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 123.9 64.3 192.9% View Chart
P/BV x 8.5 2.3 373.9% View Chart
Dividend Yield % 0.2 0.4 52.2%  

Financials

 SHASUN PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ALEMBIC LTD
Mar-18
SHASUN PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs9472 130.8%   
Low Rs4634 134.5%   
Sales per share (Unadj.) Rs214.24.7 4,556.4%  
Earnings per share (Unadj.) Rs5.36.1 87.4%  
Cash flow per share (Unadj.) Rs15.86.2 253.3%  
Dividends per share (Unadj.) Rs1.000.20 500.0%  
Dividend yield (eoy) %1.40.4 378.8%  
Book value per share (Unadj.) Rs53.340.7 131.2%  
Shares outstanding (eoy) m56.62267.03 21.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.311.3 2.9%   
Avg P/E ratio x13.18.7 151.0%  
P/CF ratio (eoy) x4.48.5 52.1%  
Price / Book Value ratio x1.31.3 100.6%  
Dividend payout %18.73.3 571.9%   
Avg Mkt Cap Rs m3,95814,139 28.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,164207 1,043.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1271,255 966.1%  
Other income Rs m229370 62.0%   
Total revenues Rs m12,3561,625 760.2%   
Gross profit Rs m1,009111 908.2%  
Depreciation Rs m59438 1,570.4%   
Interest Rs m4152 24,417.6%   
Profit before tax Rs m230442 52.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 -0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-7324 -303.6%   
Profit after tax Rs m3021,630 18.5%  
Gross profit margin %8.38.9 94.0%  
Effective tax rate %-31.75.4 -584.0%   
Net profit margin %2.5129.8 1.9%  
BALANCE SHEET DATA
Current assets Rs m6,8841,867 368.7%   
Current liabilities Rs m8,456591 1,430.3%   
Net working cap to sales %-13.0101.6 -12.7%  
Current ratio x0.83.2 25.8%  
Inventory Days Days6294 65.4%  
Debtors Days Days10874 146.2%  
Net fixed assets Rs m4,9701,791 277.5%   
Share capital Rs m113534 21.2%   
"Free" reserves Rs m2,87510,324 27.8%   
Net worth Rs m3,02010,858 27.8%   
Long term debt Rs m1,81741 4,411.2%   
Total assets Rs m13,34711,591 115.2%  
Interest coverage x1.6260.9 0.6%   
Debt to equity ratio x0.60 15,858.3%  
Sales to assets ratio x0.90.1 839.0%   
Return on assets %5.414.1 38.2%  
Return on equity %10.015.0 66.6%  
Return on capital %13.315.2 87.7%  
Exports to sales %46.41.5 2,999.3%   
Imports to sales %14.221.0 67.9%   
Exports (fob) Rs m5,62219 28,976.8%   
Imports (cif) Rs m1,728263 656.1%   
Fx inflow Rs m5,84319 30,116.5%   
Fx outflow Rs m2,173264 823.7%   
Net fx Rs m3,669-244 -1,501.3%   
CASH FLOW
From Operations Rs m398236 168.6%  
From Investments Rs m-1,635-224 729.9%  
From Financial Activity Rs m1,309-27 -4,919.5%  
Net Cashflow Rs m71-15 -481.1%  

Share Holding

Indian Promoters % 39.2 64.0 61.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.2 1,800.0%  
FIIs % 17.6 9.7 181.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.1 151.7%  
Shareholders   20,750 54,701 37.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS